Education
About Us
Working with TipRanks
Follow Us
Gaush Meditech Ltd. (HK:2407)
:2407
Total Valuation
Gaush Meditech Ltd. has a market cap or net worth of HK$1.13B. The enterprise value is HK$1.09B.
Market CapHK$1.13B
Enterprise ValueHK$1.09B
Share Statistics
Gaush Meditech Ltd. has 147,887,860 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding147,887,860
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Gaush Meditech Ltd.’s return on equity (ROE) is 0.06 and return on invested capital (ROIC) is 5.01%.
Return on Equity (ROE)0.06
Return on Assets (ROA)0.04
Return on Invested Capital (ROIC)5.01%
Return on Capital Employed (ROCE)0.10
Revenue Per Employee1.62M
Profits Per Employee175.66K
Employee Count884
Asset Turnover0.56
Inventory Turnover2.29
Valuation Ratios
The current PE Ratio of Gaush Meditech Ltd. is 10.2. Gaush Meditech Ltd.’s PEG ratio is -0.32.
PE Ratio10.2
PS Ratio0.96
PB Ratio0.87
Price to Fair Value0.87
Price to FCF51.36
Price to Operating Cash Flow8.36
PEG Ratio-0.32
Income Statement
In the last 12 months, Gaush Meditech Ltd. had revenue of 1.43B and earned 92.39M in profits. Earnings per share was 0.63.
Revenue1.43B
Gross Profit663.39M
Operating Income197.19M
Pretax Income155.29M
Net Income92.39M
EBITDA247.31M
Earnings Per Share (EPS)0.63
Cash Flow
In the last 12 months, operating cash flow was 142.55M and capital expenditures -17.40M, giving a free cash flow of 125.16M billion.
Operating Cash Flow142.55M
Free Cash Flow125.16M
Free Cash Flow per Share0.85
Dividends & Yields
Gaush Meditech Ltd. pays an annual dividend of HK$0.3, resulting in a dividend yield of 3.48%
Dividend Per ShareHK$0.3
Dividend Yield3.48%
Payout Ratio39.65%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.93
52-Week Price Change-5.69%
50-Day Moving Average8.74
200-Day Moving Average7.47
Relative Strength Index (RSI)35.37
Average Volume (3m)147.22K
Important Dates
Gaush Meditech Ltd. upcoming earnings date is Apr 1, 2026, Before Open (Confirmed).
Last Earnings DateAug 28, 2025
Next Earnings DateApr 1, 2026
Ex-Dividend Date―
Financial Position
Gaush Meditech Ltd. as a current ratio of 2.25, with Debt / Equity ratio of 28.20%
Current Ratio2.25
Quick Ratio1.60
Debt to Market Cap0.37
Net Debt to EBITDA0.53
Interest Coverage Ratio5.37
Taxes
In the past 12 months, Gaush Meditech Ltd. has paid 66.76M in taxes.
Income Tax66.76M
Effective Tax Rate0.43
Enterprise Valuation
Gaush Meditech Ltd. EV to EBITDA ratio is 6.05, with an EV/FCF ratio of 56.28.
EV to Sales1.05
EV to EBITDA6.05
EV to Free Cash Flow56.28
EV to Operating Cash Flow13.88
Balance Sheet
Gaush Meditech Ltd. has HK$383.68M in cash and marketable securities with HK$469.06M in debt, giving a net cash position of -HK$85.38M billion.
Cash & Marketable SecuritiesHK$383.68M
Total DebtHK$469.06M
Net Cash-HK$85.38M
Net Cash Per Share-HK$0.58
Tangible Book Value Per ShareHK$2.59
Margins
Gross margin is 47.29%, with operating margin of 13.80%, and net profit margin of 6.47%.
Gross Margin47.29%
Operating Margin13.80%
Pretax Margin10.87%
Net Profit Margin6.47%
EBITDA Margin17.31%
EBIT Margin13.62%
Analyst Forecast
The average price target for Gaush Meditech Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast6.63%
EPS Growth Forecast12.96%